Page last updated: 2024-12-05

dimethylol dihydroxyethyleneurea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dimethylol dihydroxyethyleneurea (DMDHEU) is a formaldehyde-based resin used in textile finishing. It is typically synthesized by reacting formaldehyde with ethyleneurea. DMDHEU is applied to fabrics to improve their wrinkle resistance, crease recovery, and dimensional stability. It is widely studied due to its effectiveness in improving the durability and appearance of textiles. DMDHEU can be used in a variety of textile applications, including cotton, polyester, and blends. It is considered a safe and effective finishing agent when used according to industry guidelines. However, some concerns have been raised about potential health effects related to formaldehyde release from DMDHEU-treated textiles, especially in the context of prolonged skin contact.'

dimethylol dihydroxyethyleneurea: used in cotton or cotton-polyester blend fabric [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15824
SCHEMBL ID213947
MeSH IDM0128266

Synonyms (77)

Synonym
2-imidazolidinone, 4,5-dihydroxy-1,3-bis(hydroxymethyl)-
1854-26-8
4,5-dihydroxy-1,3-bis(hydroxymethyl)imidazolidin-2-one
permafresh lh
firmatex rk
sumitex ns 2
permafresh 113b
cassurit lr
permafresh lf
fixapret cp 40
prox dw
depremol g
neuperm gfn
arkofix ng
dimethylol dihydroxyethyleneurea
knittex le
permafresh 183
verapret dh
fixapret cpns
nci-c60322
dimethyloldihydroxyethylene urea
fixapret cpk
sumitex ns
sarcoset gm
2-imidazolidinone, 4,5-dihydroxy-1,3-bis
einecs 217-451-6
hsdb 4358
permafresh lks
sumitex ns 1spe
reapret kpn
ccris 4804
sumitex fsk
fixapret cpn
protocol c
brn 0881343
2-imidazolidinone, 1,3-bis(hydroxymethyl)-4,5-dihydroxy-
arkofix
verapret dkh
4,5-dihydroxy-1,3-bis(hydroxymethyl)-2-imidazolidinone
n,n'-dimethylolglyoxal monoureine
fixapret cp
dimethylolglyoxalurea
readpret kpn
dmdheu
hylite lf
sumitex ns 1 spe
n,n'-dimethylol-4,5-dihydroxyethyleneurea
dimethyloldihydroxyethyleneurea
AKOS006275420
5-25-02-00369 (beilstein handbook reference)
oku7ix3h6e ,
unii-oku7ix3h6e
einecs 270-150-1
SCHEMBL213947
W-109126
DTXSID1025140
4,5-dihydroxy-2-oxo-1,3-dimethylolimidazolidine
4,5-dihydroxy-n,n'-dimethylolethyleneurea
1,3-di(hydroxymethyl)-4,5-dihydroxy-2-imidazolidinone
dihydroxydimethylolethyleneurea
n,n'-dimethylol-4,5-dihydroxy-2-imidazolidinone
dimethylolglyoxalmonoureine
1,3-dimethylol-4,5-dihydroxy-2-imidazolidinone
n,n'-dimethyloldihydroxyethyleneurea
dihydroxyethylenedimethylolurea
4,5-dihydroxy-1,3-dimethylolethyleneurea
n,n'-bis(hydroxymethyl)-4,5-dihydroxyethyleneurea
1,3-dimethylol-4,5-dihydroxyimidazolidone
1,3-bis(hydroxymethyl)-4,5-dihydroxyimidazolidone
1,3-bis(hydroxymethyl)-4,5-dihydroxy-2-imidazolidone
1,3-dimethylol-4,5-dihydroxyethyleneurea
dimethyloldihydroxyimidazolidinone
1,3-bis(hydroxymethyl)-4,5-dihydroxy-2-imidazolidinone
bis(hydroxymethyl)dihydroxyethyleneurea
4,5-dihydroxy-1,3-dimethylol-2-imidazolidinone
dimethylol dihydroxyethyleneurea [hsdb]
A857866
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.02 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (12.50%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]